Previous close | 0.1000 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 0.50 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 595 |
Advances plan to launch T2Lyme Panel for detection of early Lyme diseaseFiled Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has signed a non-binding letter of intent (“LOI”) to enter into a strat
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript May 6, 2024 T2 Biosystems, Inc. beats earnings expectations. Reported EPS is $-0.00266, expectations were $-2.2. TTOO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the T2 Biosystems, […]
Q1 2024 T2 Biosystems Inc Earnings Call